Indrayani Biotech Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Indrayani Biotech Ltd. on BSE

Load latest

Indrayani Biotech Ltd.

14 Nov 2023

13.75

-4.45%

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Outcome for Outcome Of The Board Meeting

BSE India

Board of Directors in its meeting held today i.e., on Tuesday, November 14, 2023, the Directors have inter-alia, approved the Unaudited Financial Results (Standalone and Consolidated) along with the Limited Review Report for the quarter & half year ended September 30, 2023.

pdf

Indrayani Biotech Ltd.

08 Nov 2023

13.75

-4.45%

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Intimation for Considering And Approving The Unaudited Financial …

BSE India

INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter & half year ended September 30, 2023, along with the Limited Review Report of Statutory Auditor and any other business with the permission of the Chair.

pdf

Indrayani Biotech Ltd.

07 Nov 2023

13.75

-4.45%

Corp. Note

INDRAYANI BIOTECH LTD. - 526445 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation pursuant to Regulation of 39(3) of SEBI (LODR) Regulations, 2015 is enclosed.

pdf

Indrayani Biotech Ltd.

01 Nov 2023

13.75

-4.45%

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company in its meeting held discussed, considered and approved the following amongst other subject matters: Declaration of dividend on the 12%Compulsorily Convertible Preference Shares of Rs. 10/- each of the Company, pursuant to terms and conditions of CCPS.. These shares are subject to a lock-in period as per Regulation 167 of SEBI (ICDR) Regulations Pursuant to CCPS terms, 92,50,000 Compulsorily Convertible Preference Shares have been converted into fully paid Equity shares Pursuant to terms and conditions of convertible warrants, 20,59,064 warrants have been converted into fully paid Equity shares.These shares are subject to a lock-in period as per Regulation 167 of SEBI (ICDR) Regulations.

pdf

Indrayani Biotech Ltd.

27 Oct 2023

13.75

-4.45%

Board Meeting

INDRAYANI BIOTECH LTD. - 526445 - Board Meeting Intimation for Declaration Of Preference Dividend, Conversion Of …

BSE India

INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 ,inter alia, to consider and approve To recommend Payment of dividend on 12% Compulsorily Convertible Preference Shares. To consider and approve the allotment of Equity shares by conversion of Compulsorily Convertible Preference Shares subject to lock in period of 6 months. To consider and approve the conversion of Warrants into Equity Shares subject to lock in period of 6 months. Any other matter with the permission of the chair.

pdf